- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05276661
A Project to Study Probiotic Beauty Products on Skin Improvement
Chia Nan University of Pharmacy & Science
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Twenty subjects were recruited and informed to apply the lotion gel twice per day (3~5 mg/cm2 once) for 4 weeks. Two kinds of facial lotiongels, "A" gel and "B" gel, were provided to every subject. The "A" gel (TAC/Collagen lotiongel) was applied on subjects' right face and the "B" gel (placebo lotion) on their left face (formula showed as Table S2). Ordinary cosmetics usage was permitted but any change of usage was not allowed during the intervention. Outdoor activities (sun exposure) and the usage of sunscreen lotion were not limited in this study. Every subject was required to inspect his/her skin condition on week 0 and 4. Before inspection, the face was washed with water and waited for 30 min in an air-conditioned room (25°C, humility 55 ± 5%). Among these 20 subjects, eight of them had severe acne with at least two acne lesions on each side of face when participating this trial. They were instructed for more visits to evaluate the symptom of acne on week 1 and 2.
Skin hydration (Corneometer CM825, Courage + Khazaka Electroni, Germany), sebum (Callegari 1930, Italy), and inflammation detection (Chroma Meter MM-500, Minolta, Japan) of upper cheek were measured in every subject. The improvement in inflammation was positively correlated with a decrease of a* value or an increase of L* value. VISIA® Complexion Analysis (VISIA® Complexion Analysis, U.S.A.) was also employed to measure the skin inflammation, porphyrins numbers and brown spot numbers of whole face. The result was presented as the mean value and the relative percentage (%) to the baseline.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Tainan, Taiwan, 71710
- Chia Nan University of Pharmacy & Science
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Healthy volunteers aged above 20 years old
Exclusion Criteria:
- Subject with diseases of the skin, heart, liver, kidney, endocrine and other organs and patients with mental illness (according to medical history).
- Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder.
- Female who is pregnant or nursing or planning to become pregnant during the course of the study.
- Received facial laser therapy, chemical peeling or UV overexposure in the past 4 weeks.
- Involuntary subject
- People who is taking chronic disease medication
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: "A" gel (TAC/Collagen gel)
The "A" gel (TAC/Collagen gel) was applied on subjects' right face
|
Apply it twice per day for 4 weeks
|
Placebo Comparator: "B" gel (placebo lotion)
the "B" gel (placebo lotion) on their left face
|
Apply it twice per day for 4 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effects of the TAC/Collagen Gel on Human Skin Hydration
Time Frame: Subjects will be tested in the 4th week
|
Corneometer® CM825 was utilized to measure skin moisture.
Units: arbitrary Corneometer® units 0-120
|
Subjects will be tested in the 4th week
|
Effects of the TAC/Collagen Gel on Human Skin Sebum
Time Frame: Subjects will be tested in the 4th week
|
Callegari 1930 was utilized to measure skin inflammation.
Units: arbitrary units.
|
Subjects will be tested in the 4th week
|
Effects of the TAC/Collagen gel on Human Skin Inflammation
Time Frame: Subjects will be tested in the 4th week
|
Chroma Meter MM-500 was utilized to measure skin inflammation.
Units: arbitrary units.
|
Subjects will be tested in the 4th week
|
Effect of TAC/Collagen Gel on Human Acne Healing and Porphyrins Numbers
Time Frame: Subjects will be tested in the 4th week
|
VISIA Complexion Analysis System was utilized to measure skin texture.
Units: arbitrary units
|
Subjects will be tested in the 4th week
|
Effects of the TAC/Collagen Gel on Human Skin Brown Spot Numbers
Time Frame: Subjects will be tested in the 4th week
|
VISIA Complexion Analysis System was utilized to measure skin texture.
Units: arbitrary units
|
Subjects will be tested in the 4th week
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Chia-Hua Liang, PhD, Chia Nan University of Pharmacy & Scienc
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TSMHIRB-2-R-025-2.1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Diseases
-
West Virginia UniversityMary Babb Randolph Cancer Center at West Virginia University Hospitals; West...RecruitingSkin Cancer | Skin Lesion | Skin Melanoma | Tumor SkinUnited States
-
Paratek Pharmaceuticals IncCompletedInfectious Skin Disease | Bacterial Skin DiseaseUnited States
-
R2 DermatologyCompleted
-
TCI Co., Ltd.Completed
-
Access Business GroupClinical Research LaboratoriesCompleted
-
Molnlycke Health Care ABCompletedPsoriasis | Eczema | Dry Skin; EczemaUnited Kingdom
Clinical Trials on TAC/Collagen gel
-
The Fourth Affiliated Hospital of Zhejiang University...RecruitingAlveolar Ridge Preservation | Concentrated Growth FactorChina
-
Shetty-Kim Research FoundationUnknownArticular Cartilage DefectUnited Kingdom
-
Istituto Ortopedico RizzoliCompleted
-
Novartis PharmaceuticalsTerminated
-
Andrea RavidaSigmaGraft Inc.Enrolling by invitationSurgery | Peri-ImplantitisUnited States
-
Sel Sanayi Urunleri Ticaret ve Pazarlama A.S.Alpan Farma Ar-Ge Biyoteknolojileri Ltd.Sti.Not yet recruiting
-
The Cleveland ClinicCompletedPelvic Organ Prolapse
-
Sel Sanayi Urunleri Ticaret ve Pazarlama A.S.Alpan Farma Ar-Ge Biyoteknolojileri Ltd.Sti.RecruitingSkin Manifestations | Wrinkle | SkinTurkey
-
Ain Shams UniversityActive, not recruiting
-
AZ-VUBUnknownDiabetes Mellitus, Type 1Belgium